Senior Vice President, Chemistry and Drug Discovery @ (June 2021 - September 2025)
Research Fellow @ (October 2020 - April 2021)
Head Of Department - Synthetic Medicinal Modalities, IDD @ (October 2017 - April 2021)
Research Fellow @ (October 2020 - March 2021)
Head of Insulins and Peptides, Diabetes Division @ (April 2016 - September 2017)
Director, Head of Peptides, R and TM Diabetes Division @ (October 2012 - March 2016)
Director Medicinal Chemistry and Head of Medicinal Chemistry 3 - R and D Diabetes Division @ (April 2010 - September 2012)
Senior Prinicpal Scientist @ (January 2006 - April 2010)
Research Scientist @ (February 2002 - December 2005)
Michael Wagner Education
Mainz University & Cornell University
PhD (Chemistry)
Michael Wagner Skills
Pharmaceutical Industry
Drug Discovery
Medicinal Chemistry
Therapeutic Peptides
Biopharmaceuticals
Small Molecules
Drug Delivery
Immunology
Diabetes
Pain
Cardiovascular
Thrombosis
Osteoarthritis
Pharmacology
Organic Chemistry
Drug Development
Clinical Development
CRO
Portfolio Management
Project Management
People Development
Due Diligence
Strategic Alliances
Medizinische Chemie
Pharmaforschung
Pharmaindustrie
Klinische Entwicklung
Life Sciences
R&D
Immunologie
Molecular Biology
Research and Development R
Research
Medicine
Data Analysis
Arzneimittelentwicklung
Research and Development R&d
CRO Management
Teaching
Organische Chemie
Biotechnology
Microsoft Office
Research and Development
Michael Wagner Summary
Michael Wagner, is currently a Acting CSO (NewCo) at Frontier Discovery, Inc. Michael Wagner brings experience from previous roles at undefined, Dayra Therapeutics, Inc and Dewpoint Therapeutics. Michael Wagner holds a PhD in Chemistry @ Mainz University & Cornell University. With a robust skill set that includes Pharmaceutical Industry, Drug Discovery, Medicinal Chemistry, Therapeutic Peptides, Biopharmaceuticals and more. Michael Wagner has 2 emails on RocketReach.
Looking for a different Michael Wagner?
Find contact details for 700 million professionals.